treatment regimen
We also performed extensive sensitivity analyses by adding       other dopamine agonists to the no-pramipexole treatment regimen and varying       disease progression parameters.
We also performed extensive sensitivity analyses by adding       other dopamine agonists to the no- @OBJECT$  @PREDICAT$  @SUBJECT$  and varying       disease progression parameters.